Guidelines for Perioperative Management of the Diabetic Patient

Sivakumar Sudhakaran, Salim R Surani, Sivakumar Sudhakaran, Salim R Surani

Abstract

Management of glycemic levels in the perioperative setting is critical, especially in diabetic patients. The effects of surgical stress and anesthesia have unique effects on blood glucose levels, which should be taken into consideration to maintain optimum glycemic control. Each stage of surgery presents unique challenges in keeping glucose levels within target range. Additionally, there are special operative conditions that require distinctive glucose management protocols. Interestingly, the literature still does not report a consensus perioperative glucose management strategy for diabetic patients. We hope to outline the most important factors required in formulating a perioperative diabetic regimen, while still allowing for specific adjustments using prudent clinical judgment. Overall, through careful glycemic management in perioperative patients, we may reduce morbidity and mortality and improve surgical outcomes.

References

    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(supplement 1):S62–S69. doi: 10.2337/dc10-S062.
    1. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(supplement 1):S14–S80. doi: 10.2337/dc14-s014.
    1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Atlanta, Ga, USA: US Department of Health and Human Services; 2014.
    1. Danaei G., Finucane M. M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. The Lancet. 2011;378(9785):31–40. doi: 10.1016/s0140-6736(11)60679-x.
    1. Shaw J. E., Sicree R. A., Zimmet P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14. doi: 10.1016/j.diabres.2009.10.007.
    1. Stolar M. W., Hoogwerf B. J., Gorshow S. M., Boyle P. J., Wales D. O. Managing type 2 diabetes: going beyond glycemic control. Journal of Managed Care Pharmacy. 2008;14(5):s2–s19.
    1. Nicholas J., Charlton J., Dregan A., Gulliford M. C. Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study. PLoS ONE. 2013;8(7) doi: 10.1371/journal.pone.0068008.e68008
    1. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine. 2001;345(19):1359–1367. doi: 10.1056/nejmoa011300.
    1. Capes S. E., Hunt D., Malmberg K., Gerstein H. C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. The Lancet. 2000;355(9206):773–778. doi: 10.1016/s0140-6736(99)08415-9.
    1. Wass C. T., Lanier W. L. Subspecialty clinics: anesthesiology: glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clinic Proceedings. 1996;71(8):801–812. doi: 10.1016/s0025-6196(11)64847-7.
    1. Mesotten D., van den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs. 2003;63(7):625–636. doi: 10.2165/00003495-200363070-00001.
    1. Coursin D. B., Murray M. J. How sweet is euglycemia in critically ill patients? Mayo Clinic Proceedings. 2003;78(12):1460–1462. doi: 10.4065/78.12.1460.
    1. Hirsch I. B., McGill J. B. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care. 1990;13(9):980–991. doi: 10.2337/diacare.13.9.980.
    1. Alberti K. G. M. M., Gill G. V., Elliott M. J. Insulin delivery during surgery in the diabetic patient. Diabetes Care. 1982;5(1):65–77.
    1. Reynolds C. Management of the diabetic surgical patient. A systematic but flexible plan is the key. Postgraduate Medicine. 1985;77(1):265–279.
    1. Gavin L. A. Perioperative management of the diabetic patient. Endocrinology and Metabolism Clinics of North America. 1992;21(2):457–475.
    1. Peters A., Kerner W. Perioperative management of the diabetic patient. Experimental and Clinical Endocrinology & Diabetes. 1995;103(4):213–218. doi: 10.1055/s-0029-1211353.
    1. Fetchick D. A., Fischer J. S. Perioperative management of the patient with diabetes mellitus undergoing outpatient or elective surgery. Clinics in Podiatric Medicine and Surgery. 1987;4(2):439–443.
    1. Smail P. J. Children with diabetes who need surgery. Archives of Disease in Childhood. 1986;61(4):413–414. doi: 10.1136/adc.61.4.413.
    1. Marks J. B. Perioperative management of diabetes. American Family Physician. 2003;67(1):93–100.
    1. Gill G. V., Alberti K. G. M. M. International Textbook of Diabetes Mellitus. New York, NY, USA: John Wiley & Sons; 2003. The care of the diabetic patient during surgery.
    1. Rayfield E. J., Ault M. J., Keusch G. T., Brothers M. J., Nechemias C., Smith H. Infection and diabetes: the case for glucose control. The American Journal of Medicine. 1982;72(3):439–450. doi: 10.1016/0002-9343(82)90511-3.
    1. Hempel A., Maasch C., Heintze U., et al. High glucose concentrations increase endothelial cell permeability via activation of protein kinase Cα . Circulation Research. 1997;81(3):363–371. doi: 10.1161/01.res.81.3.363.
    1. Pulsinelli W. A., Levy D. E., Sigsbee B., Scherer P., Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. The American Journal of Medicine. 1983;74(4):540–544. doi: 10.1016/0002-9343(83)91007-0.
    1. Marhoffer W., Stein M., Maeser E., Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15(2):256–260. doi: 10.2337/diacare.15.2.256.
    1. McMurry J. F., Jr. Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetes. The Surgical Clinics of North America. 1984;64(4):769–778.
    1. Walker M., Marshall S. M., Alberti K. G. M. M. Clinical aspects of diabetic ketoacidosis. Diabetes/Metabolism Reviews. 1989;5(8):651–663. doi: 10.1002/dmr.5610050803.
    1. Brenner W. I., Lansky Z., Engelman R. M., Stahl W. M. Hyperosomolar coma in surgical patients: an iatrogenic disease of increasing incidence. Annals of Surgery. 1973;178(5):651–654. doi: 10.1097/00000658-197311000-00017.
    1. Lee G. A., Wyatt S., Topliss D., Walker K. Z., Stoney R. A study of a pre-operative intervention in patients with diabetes undergoing cardiac surgery. Collegian. 2014;21(4):287–293. doi: 10.1016/j.colegn.2013.06.001.
    1. Wukich D. K. Diabetes and its negative impact on outcomes in orthopaedic surgery. World Journal of Orthopedics. 2015;6(3):331–339. doi: 10.5312/wjo.v6.i3.331.
    1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–1046. doi: 10.2337/dc12-2625.
    1. Umpierrez G. E., Isaacs S. D., Bazargan N., You X., Thaler L. M., Kitabchi A. E. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. The Journal of Clinical Endocrinology & Metabolism. 2002;87(3):978–982. doi: 10.1210/jc.87.3.978.
    1. Galloway J. A., Shuman C. R. Diabetes and surgery. A study of 667 cases. The American Journal of Medicine. 1963;34(2):177–191. doi: 10.1016/0002-9343(63)90052-4.
    1. Goldmann D. R. Surgery in patients with endocrine dysfunction. Medical Clinics of North America. 1987;71(3):499–509.
    1. Angelini G., Ketzler J. T., Coursin D. B. Perioperative care of the diabetic patient. ASA Refresher Courses in Anesthesiology. 2001;29(1):1–9. doi: 10.1097/00126869-200129010-00002.
    1. Finfer S., Bellomi R., Blair D., et al. Intensive versus conventional glucose control in critically Ill patients. The New England Journal of Medicine. 2009;360(13):1283–1297. doi: 10.1056/nejmoa0810625.
    1. Turchin A., Matheny M. E., Shubina M., Scanlon S. V., Greenwood B., Pendergrass M. L. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153–1157. doi: 10.2337/dc08-2127.
    1. Zacharias A., Habib R. H. Factors predisposing to median sternotomy complications: deep vs superficial infection. Chest. 1996;110(5):1173–1178. doi: 10.1378/chest.110.5.1173.
    1. Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999-2000. MMWR Morbidity and Mortality Weekly Report. 2003;52(35):833–837.
    1. Narayan K. M. V., Boyle J. P., Thompson T. J., Sorensen S. W., Williamson D. F. Lifetime risk for diabetes mellitus in the United States. Journal of the American Medical Association. 2003;290(14):1884–1890. doi: 10.1001/jama.290.14.1884.
    1. Hjortrup A., Sørensen C., Dyremose E., Hjortsø N. C., Kehlet H. Influence of diabetes mellitus on operative risk. British Journal of Surgery. 1985;72(10):783–785. doi: 10.1002/bjs.1800721005.
    1. Zaloga G. P. Catecholamines in anesthetic and surgical stress. International Anesthesiology Clinics. 1988;26(3):187–198. doi: 10.1097/00004311-198802630-00004.
    1. Madsen S. N., Engquist A., Badawi I., Kehlet H. Cyclic AMP, glucose and cortisol in plasma during surgery. Hormone and Metabolic Research. 1976;8(6):483–485. doi: 10.1055/s-0028-1093601.
    1. Werb M. R., Zinman B., Teasdale S. J., Goldman B. S., Scully H. E., Marliss E. B. Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. The Journal of Clinical Endocrinology & Metabolism. 1989;69(5):1010–1018. doi: 10.1210/jcem-69-5-1010.
    1. Wright P. D., Johnston I. D. A. The effect of surgical operation on growth hormone levels in plasma. Surgery. 1975;77(4):479–486.
    1. Rehman H. U., Mohammed K. Perioperative management of diabetic patients. Current Surgery. 2003;60(6):607–611. doi: 10.1016/j.cursur.2003.07.002.
    1. Fragen R. J., Shanks C. A., Molteni A., Avram M. J. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology. 1984;61(6):652–656. doi: 10.1097/00000542-198412000-00004.
    1. Forman S. A. Clinical and molecular pharmacology of etomidate. Anesthesiology. 2011;114(3):695–707. doi: 10.1097/aln.0b013e3181ff72b5.
    1. Lundy J. B., Slane M. L., Frizzi J. D. Acute adrenal insufficiency after a single dose of etomidate. Journal of Intensive Care Medicine. 2007;22(2):111–117. doi: 10.1177/0885066606298140.
    1. Desborough J. P., Hall G. M., Hart G. R., Burrin J. M. Midazolam modifies pancreatic and anterior pituitary hormone secretion during upper abdominal surgery. British Journal of Anaesthesia. 1991;67(4):390–396. doi: 10.1093/bja/67.4.390.
    1. Hall G. M., Lacoumenta S., Hart G. R., Burrin J. M. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. British Journal of Anaesthesia. 1990;65(2):251–253. doi: 10.1093/bja/65.2.251.
    1. Desborough J. P., Jones P. M., Persaud S. J., Landon M. J., Howell S. L. Isoflurane inhibits insulin secretion from isolated rat pancreatic islets of Langerhans. British Journal of Anaesthesia. 1993;71(6):873–876. doi: 10.1093/bja/71.6.873.
    1. Lattermann R., Schricker T., Wachter U., Georgieff M., Goertz A. Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery. Anesthesia and Analgesia. 2001;93(1):121–127.
    1. Wolf A. R., Eyres R. L., Laussen P. C., et al. Effect of extradural analgesia on stress responses to abdominal surgery in infants. British Journal of Anaesthesia. 1993;70(6):654–660. doi: 10.1093/bja/70.6.654.
    1. Pflug A. E., Halter J. B. Effect of spinal anesthesia on adrenergic tone and the neuroendocrine responses to surgical stress in humans. Anesthesiology. 1981;55(2):120–126. doi: 10.1097/00000542-198108000-00007.
    1. Moraca R. J., Sheldon D. G., Thirlby R. C. The role of epidural anesthesia and analgesia in surgical practice. Annals of Surgery. 2003;238(5):663–673. doi: 10.1097/.
    1. Meneghini L. F. Perioperative management of diabetes: translating evidence into practice. Cleveland Clinic Journal of Medicine. 2009;76(4):S53–S59. doi: 10.3949/ccjm.76.s4.09.
    1. Moghissi E. S., Korytkowski M. T., DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–1131. doi: 10.2337/dc09-9029.
    1. Giakoumidakis K., Eltheni R., Patelarou E., et al. Effects of intensive glycemic control on outcomes of cardiac surgery. Heart & Lung: The Journal of Acute and Critical Care. 2013;42(2):146–151. doi: 10.1016/j.hrtlng.2012.12.007.
    1. Umpierrez G. E., Kitabchi A. E. Diabetic ketoacidosis: risk factors and management strategies. Treatments in Endocrinology. 2003;2(2):95–108. doi: 10.2165/00024677-200302020-00003.
    1. McCavert M., Mone F., Dooher M., Brown R., O'Donnell M. E. Peri-operative blood glucose management in general surgery—a potential element for improved diabetic patient outcomes—an observational cohort study. International Journal of Surgery. 2010;8(6):494–498. doi: 10.1016/j.ijsu.2010.06.017.
    1. Pietropaolo M. An 18-year-old patient with type 1 diabetes undergoing surgery. PLoS Medicine. 2005;2(5, article e140) doi: 10.1371/journal.pmed.0020140.
    1. Clement S., Braithwaite S. S., Magee M. F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–591. doi: 10.2337/diacare.27.2.553.
    1. Bailey C. J., Turner R. C. Metformin. The New England Journal of Medicine. 1996;334(9):574–579. doi: 10.1056/nejm199602293340906.
    1. Williams G. Management of non-insulin-dependent diabetes mellitus. The Lancet. 1994;343(8889):95–100. doi: 10.1016/s0140-6736(94)90822-2.
    1. Toeller M. α-glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. European Journal of Clinical Investigation. 1994;24(supplement 3):31–35.
    1. Saltiel A. R., Olefsky J. M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 1996;45(12):1661–1669. doi: 10.2337/diab.45.12.1661.
    1. Groop L. C. Sulfonylureas in NIDDM. Diabetes Care. 1992;15(6):737–754. doi: 10.2337/diacare.15.6.737.
    1. Alexanian S. M., McDonnell M. E., Akhtar S. Creating a perioperative glycemic control program. Anesthesiology Research and Practice. 2011;2011:9. doi: 10.1155/2011/465974.465974
    1. Duncan A. E., Abd-Elsayed A., Maheshwari A., Xu M., Soltesz E., Koch C. G. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology. 2010;112(4):860–871. doi: 10.1097/aln.0b013e3181d3d4b4.
    1. Furnary A. P., Zerr K. J., Grunkemeier G. L., Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. The Annals of Thoracic Surgery. 1999;67(2):352–362. doi: 10.1016/s0003-4975(99)00014-4.
    1. Li J.-Y., Sun S., Wu S.-J. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus: undergoing coronary artery bypass surgery. Texas Heart Institute Journal. 2006;33(4):445–451.
    1. Stockton L., Baird M., Cook C. B., et al. Development and implementation of evidence-based guidelines for IV insulin: a statewide collaborative approach. Insulin. 2008;3(2):67–77. doi: 10.1016/s1557-0843(08)80018-8.
    1. Markovitz L. J., Wiechmann R. J., Harris N., et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocrine Practice. 2002;8(1):10–18. doi: 10.4158/ep.8.1.10.
    1. Goldberg P. A., Siegel M. D., Sherwin R. S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461–467. doi: 10.2337/diacare.27.2.461.
    1. Puskarich M. A., Runyon M. S., Trzeciak S., Kline J. A., Jones A. E. Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis. Journal of Clinical Pharmacology. 2009;49(7):758–767. doi: 10.1177/0091270009334375.
    1. Mehta S. R., Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. The Journal of the American Medical Association. 2005;293(4):437–446. doi: 10.1001/jama.293.4.437.
    1. Fath-Ordoubadi F., Beatt K. J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96(4):1152–1156. doi: 10.1161/01.cir.96.4.1152.
    1. Breithaupt T. Postoperative glycemic control in cardiac surgery patients. Proceedings (Baylor University Medical Center) 2010;23(1):79–82.
    1. Marik P. E., Bellomo R. Stress hyperglycemia: an essential survival response! Critical Care. 2013;17(2, article 305) doi: 10.1186/cc12514.
    1. Seres D. S., Valcarcel M., Guillaume A. Advantages of enteral nutrition over parenteral nutrition. Therapeutic Advances in Gastroenterology. 2013;6(2):157–167. doi: 10.1177/1756283x12467564.
    1. Umpierrez G. E., Smiley D., Zisman A., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 Trial) Diabetes Care. 2007;30(9):2181–2186. doi: 10.2337/dc07-0295.
    1. Jacober S. J., Sowers J. R. An update on perioperative management of diabetes. Archives of Internal Medicine. 1999;159(20):2405–2411. doi: 10.1001/archinte.159.20.2405.
    1. Rice M. J., Pitkin A. D., Coursin D. B. Glucose measurement in the operating room: more complicated than it seems. Anesthesia and Analgesia. 2010;110(4):1056–1065. doi: 10.1213/ane.0b013e3181cc07de.
    1. Mraovic B., Schwenk E. S., Epstein R. H. Intraoperative accuracy of a point-of-care glucose meter compared with simultaneous central laboratory measurements. Journal of Diabetes Science and Technology. 2012;6(3):541–546. doi: 10.1177/193229681200600308.
    1. Kalimo H., Olsson Y. Effects of severe hypoglycemia on the human brain. Neuropathological case reports. Acta Neurologica Scandinavica. 1980;62(6):345–356.
    1. Haga K. K., McClymont K. L., Clarke S., et al. The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: a systematic review and meta-analysis. Journal of Cardiothoracic Surgery. 2011;6(1, article 3) doi: 10.1186/1749-8090-6-3.
    1. Kalra P., Anakal M. Peripartum management of diabetes. Indian Journal of Endocrinology and Metabolism. 2013;17(supplement 1):S72–S76. doi: 10.4103/2230-8210.119510.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir